Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-Current Assets (2020 - 2023)

Terns Pharmaceuticals' Non-Current Assets history spans 4 years, with the latest figure at $1.2 million for Q3 2023.

  • For Q3 2023, Non-Current Assets fell 39.87% year-over-year to $1.2 million; the TTM value through Sep 2023 reached $6.1 million, down 24.11%, while the annual FY2022 figure was $1.8 million, 61.49% up from the prior year.
  • Non-Current Assets reached $1.2 million in Q3 2023 per TERN's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.6 million in Q1 2022 to a low of $1.1 million in Q3 2021.
  • Average Non-Current Assets over 4 years is $1.6 million, with a median of $1.4 million recorded in 2020.
  • Peak YoY movement for Non-Current Assets: soared 113.34% in 2022, then crashed 39.87% in 2023.
  • A 4-year view of Non-Current Assets shows it stood at $1.4 million in 2020, then fell by 19.77% to $1.1 million in 2021, then soared by 61.49% to $1.8 million in 2022, then crashed by 33.08% to $1.2 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Non-Current Assets are $1.2 million (Q3 2023), $1.4 million (Q2 2023), and $1.6 million (Q1 2023).